Revenue
attach_money-2M EUR
YoY -851.1%
IPHAInnate Pharma S.A.$ --
Innate Pharma S.A.
IPHA
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-28M EUR
YoY -10.8%
Net Income
verified-28M EUR
YoY -11.8%
EPS
paid-0.28EUR
YoY +6.7%
Revenue
EUR-2.1M
MISS
EUR12M
EUR4.9M
Q2
EUR2.2M
EUR-2.1M
EUR14.1M
EUR2.8M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
-2.3M EUR-851.1%
Net Income
EUR-27.6M
MISS
EUR-24.2M
EUR-21.3M
EUR-10.4M
EUR-27.6M
EUR-34.7M
EUR-49M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
-2.9M EUR-11.8%
Surprise History
ActualEstimate
FY2025MISS